Characterization of a novel mutation in NS1 protein of influenza A virus induced by a chemical substance for the attenuation of pathogenicity

Keyphrases

• Influenza Virus 100%
• Attenuation 100%
• Pathogenicity 100%
• Resistant Virus 100%
• Chemical Substances 100%
• Novel mutation 100%
• NS1 Protein 100%
• NS1′ 100%
• Virus-infected Cell 75%
• Wild Type Virus 50%
• Nucleoprotein 50%
• Live Attenuated Influenza Vaccine 50%
• Expression Level 25%
• Apoptosis 25%
• Akt Phosphorylation 25%
• Interferon-α (IFN-α) 25%
• Apoptosis Induction 25%
• Virus 25%
• Caspase-3 25%
• Phosphatidylinositol 3-kinase/Akt Signaling 25%
• AKT Pathway 25%
• Nuclear Export 25%
• Streptomyces Sp. 25%
• PARP Inhibitor (PARPi) 25%
• Vaccination 25%
• Sequence Analysis 25%
• Furan Derivatives 25%
• Novel Methodology 25%
• Propane-1,2,3-triol 25%
• Favorable mutations 25%
• Vaccine Candidate 25%
• H1N1 Subtype 25%

Immunology and Microbiology

• Influenzavirus A 100%
• Pathogenicity 100%
• Wild Type 50%
• Virus Type 50%
• Nucleoprotein 50%
• Influenza Vaccine 50%
• Influenza A Virus (H1N1) 50%
• interferon 25%
• Caspase 25%
• Signal Transduction 25%
• Akt Signaling 25%
• Influenza 25%
• Streptomyces 25%
• Nuclear Export 25%
• Virus Mutant 25%